Discontinued — last reported Q4 '24
Business Segments · Total Assets
Prescription Technology Solutions — Total Assets
McKesson Prescription Technology Solutions — Total Assets increased by 5.2% to $4.39B in Q1 2024 compared to the prior quarter.
Analysis
StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ4 2020
Last reportedQ4 2024May 8, 2024
Rolls up toTotal Assets
How to read this metric
An increase typically signals capital expansion, strategic acquisitions, or investment in technology infrastructure, while a decrease may indicate asset divestitures, depreciation, or impairment charges.
Detailed definition
This metric represents the total economic resources controlled by the Prescription Technology Solutions business segment...
Peer comparison
Comparable to segment-level asset bases in other healthcare technology or pharmacy services divisions, often benchmarked against segment revenue to assess asset turnover efficiency.
Metric ID:
mck_segment_prescription_technology_solutions_total_assetsHistorical Data
3 periods
| Q4 '22 | Q4 '23 | Q4 '24 | |
|---|---|---|---|
| Value | $3.53B | $4.17B | $4.39B |
| QoQ Change | — | +18.1% | +5.2% |
| YoY Change | — | +18.1% | +5.2% |
Range$3.53B – $4.39B
Avg YoY Growth+11.7%
Median YoY Growth+11.7%
Current Streak2+ quarters growth
Similar Metrics at Other Companies
Frequently Asked Questions
- What is McKesson's prescription technology solutions — total assets?
- McKesson (MCK) reported prescription technology solutions — total assets of $4.39B in Q1 2024.
- What does prescription technology solutions — total assets mean?
- The total value of all assets owned and controlled by the Prescription Technology Solutions business segment.